Engineers gut bacteria to develop living medicines for treating chronic diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Novome Biotechnologies is engineering bacteria from the human gut to treat diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Novome Biotechnologies Management Team
Investors
5AM Ventures
Alexandria Venture Investments
Alta Partners
DCVC
Mayo Clinic
Novome Biotechnologies Valuations & Financials
View real-time NPM data on Novome Biotechnologies stock including daily Novome Biotechnologies stock price estimates, valuation history, and historical share price information. Access Novome Biotechnologies financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Novome Biotechnologies pricing across six independent market signals. Looking for private company due diligence data sources on Novome Biotechnologies? Get in touch to learn more.
Similar Companies
like Novome Biotechnologies
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Vectra
Cybersecurity
Provides AI-powered cybersecurity solutions for detecting and responding to network threats across hybrid environments.
NanoCellect Biomedical
Healthcare & Life Sciences
Develops cell analysis systems that enable precise isolation and characterization of individual cells for research workflows.
Netlify
Enterprise Software
A platform that automates code to create high-performing websites and web apps, providing developers with a robust toolset for modern web projects.
misterb&b
Commerce & Marketplaces
Connecting LGBTQ+ travelers with welcoming, community-driven lodging hosted by verified allies and sharing authentic local experiences.
Maven
Healthcare & Life Sciences
On-demand digital care clinic that assists mothers and families.
Dragonboat
Enterprise Software
Orchestrating strategy, roadmaps, execution, and insights with AI-powered visibility and guidance across product portfolios.
Sirnaomics
Healthcare & Life Sciences
Pioneers RNA therapeutics that target high‑impact diseases using sophisticated delivery platforms.
FAQ
We have answers
Novome Biotechnologies stock does not trade on public stock exchanges. Novome Biotechnologies stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Novome Biotechnologies stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Novome Biotechnologies Stock does not trade on public stock exchanges. In order to sell Novome Biotechnologies shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Novome Biotechnologies does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Novome Biotechnologies share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Novome Biotechnologies stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Novome Biotechnologies stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Novome Biotechnologies stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Novome Biotechnologies is a private company and has not had an IPO. There is currently no Novome Biotechnologies IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Novome Biotechnologies IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
